Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 15.555 USD 0.74%
Market Cap: 2.4B USD

Wall Street
Price Targets

ADPT Price Targets Summary
Adaptive Biotechnologies Corp

Wall Street analysts forecast ADPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADPT is 20.691 USD with a low forecast of 18.18 USD and a high forecast of 23.1 USD.

Lowest
Price Target
18.18 USD
17% Upside
Average
Price Target
20.691 USD
33% Upside
Highest
Price Target
23.1 USD
49% Upside
Adaptive Biotechnologies Corp Competitors:
Price Targets
CSBR
Champions Oncology Inc
82% Upside
TKNO
Alpha Teknova Inc
95% Upside
INNOVACAP
Innova Captab Ltd
17% Upside
688046
GemPharmatech Co Ltd
37% Upside
SAILIFE
Sai Life Sciences Ltd
20% Upside
IQV
IQVIA Holdings Inc
14% Upside
AZTA
Azenta Inc
12% Upside
ANTHEM
Anthem Biosciences Ltd
12% Upside

Revenue
Forecast

Revenue Estimate
Adaptive Biotechnologies Corp

For the last 6 years the compound annual growth rate for Adaptive Biotechnologies Corp's revenue is 21%. The projected CAGR for the next 4 years is 22%.

21%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Adaptive Biotechnologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Adaptive Biotechnologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADPT's stock price target?
Price Target
20.691 USD

According to Wall Street analysts, the average 1-year price target for ADPT is 20.691 USD with a low forecast of 18.18 USD and a high forecast of 23.1 USD.

What is Adaptive Biotechnologies Corp's Revenue forecast?
Projected CAGR
22%

For the last 6 years the compound annual growth rate for Adaptive Biotechnologies Corp's revenue is 21%. The projected CAGR for the next 4 years is 22%.

Back to Top